Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 2,111,000 $ 5,535,000
Cost of revenue 17,441,000 2,381,000
Gross (loss) profit (15,330,000) 3,154,000
Selling, general and administrative expenses 32,426,000 19,483,000
Research and development expenses 10,803,000 17,831,000
Operating loss (58,559,000) (34,160,000)
Other (expense) income:    
Change in fair value of equity investments (4,185,000) 0
Change in fair value of liability classified warrants 0 0
Interest expense, net (28,000) (7,000)
Other income 202,000 1,842,000
Total other (expense) income, net: (4,011,000) 1,835,000
Loss before income taxes (62,570,000) (32,325,000)
Provision for income taxes 0 0
Net loss (62,570,000) (32,325,000)
Other comprehensive loss    
Foreign currency translation adjustment (61,000) (33,000)
Total comprehensive loss $ (62,631,000) $ (32,358,000)
Net loss per share:    
Basic (in dollars per share) $ (0.19) $ (0.12)
Diluted (in dollars per share) $ (0.19) $ (0.12)
Weighted average shares outstanding    
Diluted (in shares) 334,919,905 275,958,168
Basic (in shares) 334,919,905 275,958,168